[HTML][HTML] Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative

…, C Hooper, YS Hwang, DK Hwang, X Juanola… - Ophthalmology, 2018 - Elsevier
Topic An international, expert-led consensus initiative to develop systematic, evidence-based
recommendations for the treatment of noninfectious uveitis in the era of biologics. Clinical …

[HTML][HTML] The value of repeat biopsy in lupus nephritis flares

…, X Fulladosa, O Capdevila, J Torras, X Juanola… - Medicine, 2017 - journals.lww.com
Whether a repeat renal biopsy is helpful during lupus nephritis (LN) flares remains debatable.
In order to analyze the clinical utility of repeat renal biopsy in this complex situation, we …

Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER)

E Collantes, P Zarco, E Muñoz, X Juanola… - …, 2007 - academic.oup.com
Objective. The national registry of spondyloarthropathies (REGISPONSER) is launched to
classify patients with this group of diseases treated in Spanish rheumatology clinics. This …

Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis

…, MLG Vivar, J Gratacos, X Juanola… - Arthritis & …, 2019 - Wiley Online Library
Objective To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo‐controlled
studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included patients …

Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis

…, C Gómez-Vaquero, X Juanola… - Seminars in arthritis and …, 2007 - Elsevier
OBJECTIVE: To determine the impact of prior corticosteroid treatment on temporal artery
biopsy (TAB) yield to establish the diagnosis of giant cell arteritis (GCA). METHODS: …

Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis

…, I Van der Horst-Bruinsma, X Juanola… - Annals of the …, 2006 - ard.bmj.com
Objective: To compare the efficacy, pharmacokinetics and safety of etanercept 50 mg once
weekly with 25 mg twice weekly and placebo in patients with ankylosing spondylitis. Methods: …

[PDF][PDF] Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage

…, JC Torre-Alonso, X Juanola… - Clinical and …, 2010 - clinexprheumatol.org
Objectives. To determine the prevalence of fibromyalgia (FM) in ankylosing spondylitis (AS).
To evaluate the effect of FM on the measures of activity in AS. To analyse predictive factors …

[HTML][HTML] Treatment failure in axial spondyloarthritis: insights for a standardized definition

X Juanola, MJM Ramos, JM Belzunegui… - Advances in …, 2022 - Springer
… In line with the ASAS classification, axial SpA encompasses two subsets of patients: those
with radiographic sacroiliitis visible on X-rays (ankylosing spondylitis [AS] or radiographic …

[PDF][PDF] Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis

…, D Roig-Vilaseca, X Juanola… - Clinical & …, 2008 - clinexprheumatol.org
Objective. To evaluate whether concomitant treatment with low-dose aspirin or other antiplatelet
agents have an impact on the risk of severe ischemic complications and in the outcome …

First signs and symptoms of spondyloarthritis—data from an inception cohort with a disease course of two years or less (REGISPONSER-Early)

…, R Almodovar, J Gratacos, J Mulero, X Juanola… - …, 2009 - academic.oup.com
Objective. To determine the first signs and symptoms, and the clinical, biological and
radiological characteristics of patients with early SpA. Methods. A total of 150 SpA patients were …